Dolutegravir 50mg + Rilpivirina 25mg Tablet Procurement
About This Opportunity
TranslatedThis tender pertains to the procurement of the medication Dolutegravir 50mg combined with Rilpivirina 25mg in tablet form. The objective is to ensure a steady supply of this essential antiretroviral medication, which is critical for the treatment of HIV. Interested suppliers are expected to provide detailed information regarding their capacity to deliver the specified medication, including compliance with quality standards and regulatory requirements. The procurement process aims to identify qualified vendors who can meet the demand efficiently and reliably. Key requirements may include the submission of relevant certifications, proof of previous experience in supplying similar pharmaceutical products, and adherence to the stipulated delivery timelines. This tender is particularly significant in the healthcare sector, focusing on improving access to vital treatments for patients. The location for the delivery of the medication will be specified in the tender documents, and it is essential for bidders to be aware of any logistical considerations involved in the supply chain. Overall, this procurement initiative is part of a broader effort to enhance public health outcomes and ensure that patients receive necessary medical treatments in a timely manner.
This is a supplies contract in the health and medical services, transport and logistics and trade and industry sectors, with a focus on Pharmaceuticals, Infectious Diseases, Logistics and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 2,736.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender for the acquisition of Dolutegravir 50mg and Rilpivirina 25mg combination tablets is currently open in Portugal, as announced on the BASE portal, which serves as a centralized platform for public contracts across the mainland and autonomous regions of the country.
This procurement aims to secure a critical antiretroviral medication used in the treatment of HIV, reflecting the ongoing commitment of Portuguese health authorities to enhance the quality of care for individuals living with the virus.
Potential bidders are expected to demonstrate compliance with regulatory standards, ensuring that the products offered meet the necessary safety and efficacy requirements established by the European Medicines Agency (EMA) and local health authorities. Typical requirements for this type of tender include the provision of detailed product specifications, proof of good manufacturing practices (GMP), and evidence of prior successful deliveries within the pharmaceutical sector.
Moreover, bidders may be required to submit a comprehensive pricing structure, alongside potential delivery timelines and logistics capabilities. Given the critical nature of the medication, prompt delivery and reliable supply chains will likely be essential criteria in the evaluation process.
This tender represents an opportunity for pharmaceutical companies to contribute to public health initiatives in Portugal and to support the government's efforts in combating HIV through effective treatment options.
Interested suppliers are encouraged to review the tender documentation thoroughly and prepare their submissions in accordance with the outlined requirements.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 12, 2026. Last refreshed 6 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde da Cova da Beira, E. P. E.
Unidade Local de Saúde da Cova da Beira, E. P. E. has issued 422 procurement notices on BidsFactory, including 5 currently open and 394 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €2,736. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to VIIVHIV HEALTHCARE, UNIPESSOAL LDA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde da Cova da Beira, E. P. E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.